The shingles vaccine not only offers protection against the painful viral infection, but a new study suggests that the two-dose shot also may slow the progression of dementia.

Dynavax Technologies Corporation (NASDAQ:DVAX) announced topline results from Part 1 of its randomized, observer-blinded, and active-controlled Phase 1/2 clinical trial of Z-1018, a shingles vaccine ...

The research analyzed health records of older adults in Wales, where a shingles vaccination program was introduced in 2013. The study found that receiving the vaccine reduced the ...

A doctor has highlighted the 'flu-like' symptoms that could actually be an indication of a more serious condition. Dr John Burke, Chief Medical Officer at AXA Health insurance, has shed light on the ...